IonQ spent most of last year as one of the market's favorite lottery tickets.
The quantum computing company saw its share price climb past $50 in early 2025, up more than 200% in a matter of months, as retail traders piled into anything with "quantum" in the name.
The stock has given back roughly 40% from its high, and the daily swings have gotten violent enough to wipe out a typical investor's gains in a single session.
What's driving the whiplash isn't a product recall or an earnings miss.
IonQ booked about $43 million in revenue over the past year while carrying a market value that briefly topped $10 billion—a price-to-sales ratio north of 200.
For comparison, Nvidia trades around 25 times sales.
The bull case rests on a real technology shift.
Quantum computers could eventually crack problems in drug discovery and logistics that regular computers can't touch in a reasonable timeframe.
IonQ's trapped-ion approach has landed partnerships with Amazon, Microsoft, and the Air Force Research Lab.
But "eventually" is doing a lot of work in that sentence.
Useful, fault-tolerant quantum computing is still years away by most expert estimates, and competitors like IBM, Google, and a wave of well-funded startups are chasing the same prize.
IonQ also faces the classic small-cap problem: no profits, negative cash flow, and a habit of issuing new shares to fund operations.
For everyday investors watching this from a 401(k) or brokerage app, the lesson isn't that quantum is fake.
It's that a stock trading at 200 times sales has no cushion.
When sentiment turns, there's no dividend, no earnings floor, and no buyback to catch the fall.
All that's left is the next buyer's willingness to pay more.
If you're tempted to buy the dip, treat it like the speculative bet it is.
Position sizing matters more than timing.
Money you'd need within five years doesn't belong here, and neither does anything you'd panic-sell on a red morning.
A 5% allocation that you can watch drop 50% without losing sleep is very different from a 30% bet you're checking every hour.
Watch the cash burn and share count as closely as the price.
If IonQ keeps diluting shareholders to stay afloat, a rising stock price can still leave you with a smaller slice of the pie.
Revenue growth and customer contracts matter, but so does how the company pays for them.
The quantum story may well pay off for someone.
The question is whether that someone is you, or the trader who sold you the shares at the top.
My take: IonQ is a venture-capital-style bet wearing a stock ticker, and most retail portfolios aren't built for that kind of ride.
If you can't explain in one sentence why the company wins, you probably don't need to own it.
Final Thoughts
Watch, learn, and let the hype cool before you commit real money.